Tumor necrosis factor-α induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor

Blood

Volumn 88, Issue 3, 1996, Pages 922-927

  Van Der Poll, Tom ^b   Jansen, Patty M ^b   Van Zee, Kimberly J ^b   Welborn III, M Burress ^b   De Jong, Irma ^b   Hack, C Erik ^b   Loetscher, Hansruedi ^b   Lesslauer, Werner ^b   Lowry, Stephen F ^a   Moldawer, Lyle L ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BACTERIAL TOXIN; PHOSPHOLIPASE A2; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ARTICLE; BABOON; BLOOD CLOTTING; DEGRANULATION; ENDOTOXEMIA; ENZYME INDUCTION; ENZYME RELEASE; FEMALE; FIBRINOLYSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; ANTIGENS, CD; BLOOD COAGULATION; FIBRINOLYSIS; LEUKOCYTE ELASTASE; MUTAGENESIS, SITE-DIRECTED; NEUTROPHILS; PANCREATIC ELASTASE; PAPIO; PHOSPHOLIPASES A; POINT MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2042429009     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411, 1992
2. van der Poll T, Lowry SF: Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3:1, 1995
3. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662, 1987
4. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A. Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470, 1986
5. van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622, 1990
6. van der Poll T, Levi M, Büller HR, van Deventer SJH, de Boer JP, Hack CE, ten Cate JW: Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729, 1991
7. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151, 1992
8. Tartaglia LA, Weber RF, Figari IS, Reynolds CMA, Palladino J, Goeddel DV: Two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292, 1991
9. Loetscher H, Stueber D, Banner D, Mackay F, Lesslauer W: Human tumor necrosis factor a (TNFα) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 268:26350, 1993
10. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W: Tumor necrosis factor a (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277, 1993
11. Slowik MR, De Luca LG, Fiers W, Pober JS: Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 143:1724, 1993
12. Menegazzi R, Cramer R, Patriarca P, Scheurich P, Dri P: Evidence that tumor necrosis factor α (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood 84:287, 1994
13. Barabara JAJ, Smith WB, Gamble JR, van Ostade X, Vandenabeele P, Tavernier J, Fiers W, Vadas MA, Lopez AF: Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor-and p75 receptor-selective TNF-α mutants. EMBO J 13:843, 1994
14. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R: Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med 171:415, 1990
15. Tartaglia LA, Pennica D, Goeddel DV: Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:18542, 1993
16. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Krönke M, Mak TW: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457, 1993
17. Rothe J, Lesslauer W, Lötscher H, Lang Y, Koebel P, Köntgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798, 1993
18. Welborn MB III, Van Zee KJ, Edwards PD, Pruitt JH, Kaibara A, Vauthey JN, Castelman WL, Lowry SF, Kenney JS, Stuber D, Ettlin U, Wipf B, Loetscher H, Copeland EM III, Lesslauer W, Moldawer LL: A human tumor necrosis factor (TNF) p75 agonist stimulates in vitro T-cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med 1996 (in press)
19. Pixley RA, DeLa Cadena RA, Page JD, Kaufman N, Wyshock EG, Colman RW, Chang A, Taylor FB Jr: Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol 140:897, 1992
20. Pixley RA, De La Cadena R, Page JD, Kaufman N, Wyshock EG, Chang A, Taylor FB Jr, Colman RW: The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteremia. J Clin Invest 91:61, 1993
21. Levi M, ten Cate H, van der Poll T, van Deventer SJH: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975, 1993
22. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33:127, 1991
23. Creasey AA, Chang ACK, Feigen L, Wün TC, Taylor FB Jr, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91:2850, 1993
24. Levi M, Ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, Van Deventer SJH, Hack CE, Ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93:114, 1994
25. Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR: Endothelial cells stimulated with tumor necrosis factor-α express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 93:2073, 1994
26. Fischer E, Marano MA, Barber AE, Hudson A, Lee K, Rock CS, Hawes AS, Thompson RC, Hayes TJ, Anderson TD, Benjamin WR, Lowry SF, Moldawer LL: Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates. Am J Physiol 261:R442, 1991
27. van der Poll T, Fischer E, Coyle SM, van Zee KJ, Pribble JP, Stiles DM, Barie PS, Buurman WA, Moldawer LL, Lowry SF: Interleukin 1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis. J Infect Dis 172:577, 1995
28. De Boer JP, Creasy AA, Chang A, Roem D, Brouwer MC, Eerenberg AJM, Hack CE, Taylor FB Jr: Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock:39, 59, 1993
29. 2 in sepsis: Studies in non-human primates following interleukin-1α administration and during lethal bacteremia. Blood 86:1027, 1995
30. 1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators of fatal sepsis. J Lab Clin Med 119:159, 1992
31. 3 in arthritic plasma using a newly developed sandwich ELISA. Br J Rheumatol 31:175, 1992
32. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320:1165, 1989
33. Van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 76:2520, 1990
34. DeLa Cadena RA, Suffredini AF, Page JD, Pixley RA, Kaufmann N, Parillo JE, Colman RW: Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 81:3313, 1993
35. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740, 1986
36. Scarpati EM, Sadler JE: Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 264:20705, 1989
37. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ: Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263:5797, 1988
38. Hooper WC, Philips DJ, Ribeiro MJA, Benson JM, George VG, Ades EW, Evatt BL: Tumor necrosis factor-α downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line. Blood 84:483, 1994
39. Paleolog EM, Delasalle SAJ, Buurman WA, Feldmann M: Functional activities of receptors for tumor necrosis factor-α on human vascular endothelial cells. Blood 84:2578, 1994
40. Schmid EF, Binder K, Grell M, Scheurich P, Pfizenmaier K: Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial cell tissue factor expression by juxtacrine tumor necrosis factor α. Blood 86:1836, 1995
41. Burnett D, Chamba A, Hill SL, Stockley RA: Effects of plasma, tumour necrosis factor, endotoxin and dexamethasone on extracellular proteolysis by neutrophils from healthy subjects and patients with emphysema. Clin Sci 77:35, 1989
42. van der Poll T, van Deventer SJH, Hack CE, Wolbink GJ, Aarden LA, Büller HR, ten Gate JW: Effects on leukocytes following injection of tumor necrosis factor into healthy humans. Blood 79:693, 1992
43. Abe Y, Osuka Y, Nakata T, Kashu Y, Kimura S: The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro. Cytokine 7:39, 1995
44. 2 regulates critical inflammatory mediators of multiple organ failure. J Surg Res 56:199, 1994
45. 2 secretion from rat renal mesangial cells. Biochem J 273:199, 1991
46. van der Poll T, van Deventer SJH, Büller HR, Sturk A, ten Cate JW: Comparison of the early dynamics of systematic prostacyclin release after administration of tumor necrosis factor and endotoxin to healthy humans. J Infect Dis 164:599, 1991